ClinicalTrials.Veeva

Menu

Interventions for Postoperative Delirium: Biomarker-2 (IPOD-B2)

University of Wisconsin (UW) logo

University of Wisconsin (UW)

Status

Completed

Conditions

Delirium

Treatments

Procedure: High Density-Electroencephalogram

Study type

Observational

Funder types

Other

Identifiers

NCT02926417
A530900 (Other Identifier)
2015-0960
SMPH/ANESTHESIOLOGY/ANESTHESIO (Other Identifier)
Protocol Version 4/20/2020 (Other Identifier)

Details and patient eligibility

About

The IPOD-B2 Study aims to understand the pathogenesis of postoperative delirium in patients undergoing major surgery. The investigators will identify then correlate soluble biomarkers in blood and cerebral spinal fluid with changes in High Density-Electroencephalogram.

Enrollment

32 patients

Sex

All

Ages

21+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Adult (>21 years old)
  2. Patients scheduled for an elective open thoracoabdominal aortic aneurysm or TEVAR (thoracic endovascular aortic/aneurysm repair)
  3. Requiring spinal drain for surgery that is predicted to stay in two or more days
  4. Willing and able to provide informed consent

Exclusion criteria

  1. Contraindication for spinal drain
  2. Documented history of dementia
  3. Unable to communicate with the research staff due to language barriers
  4. Individuals who the PI determines are not appropriate for the study such as a history of appointment cancellations.
  5. Pregnant or Nursing
  6. Prisoners

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems